[1]
J. Campagna, “Identification of a Papain-Like Protease Inhibitor with Potential for Repurposing in Combination with an Mpro Protease Inhibitor for Treatment of SARS-CoV-2”, acbr, vol. 6, no. 6, pp. 993–1002, Dec. 2022.